Gamble Sean sold (to issuer) $5.3M of CNK (indirect holdings)

Gamble Sean (Chief Executive Officer) sold (to issuer) 138,884 indirectly-held shares of Cinemark Holdings, Inc. (CNK) at $38.19 ($5.30M total) on 2026-08-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gamble Sean
Published Aug 25, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 8:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CNK
Neutral
medium confidence
Mentioned
$CNK
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNKNeutralLow
01

Why it matters

The sale reduces the CEO's ownership but does not alter control; market may price in modest sell pressure.

02

Market read

Primary insider sale; relevant for short‑term traders monitoring executive activity.

03

What to watch

Sale executed via pre‑arranged 10b5‑1 plan, reducing informational asymmetry.

Relevance 5/10Novelty 7/10Timing: post‑market 2026‑08‑24 filing

Background

Form 4 filing discloses insider transactions required by SEC; provides transparency on executive holdings.

Company-level read

Ticker impact

$CNKNeutralMedium confidence
Context

CEO Sean Gamble sold 138,884 shares for $5.3M via a 10b5-1 plan, reducing his stake to 446,678 shares.

Expected impact

Potential slight downward pressure in short term.

Evidence & confidence

CEO sale of $5M is notable but not large enough to trigger major price moves; market may view as routine.

Market effects

Minimal impact on entertainment/film exhibition sector.

None beyond US equity market.

Limited to investors tracking insider activity.

Counterpoint

Insider sale could be a strategic tax move, not a lack of confidence.

Key entities

  • Cinemark Holdings, Inc.

    US‑listed cinema operator (ticker CNK).

  • Sean Gamble

    Chief Executive Officer of Cinemark.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.